Applications including "Draft for USP"

LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC InertSearch InertSustain AQ-C18
LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC InertSearch Inertsil ODS-3
LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC InertSearch InertSustain C18
LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LC InertSearch Inertsil NH2
GA387 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

GC InertSearch InertCap FFAP
LB912 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB911 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LC InertSearch InertSustain AQ-C18 HP
LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LC InertSearch InertSustainSwift C18
LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LC InertSearch Inertsil ODS-3
LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LC InertSearch InertSustain C18
LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph
LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph-3
LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenylhexyl
LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenyl

Applications including "Draft for USP"

LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

GA387 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LB912 - Analysis of Metformin Hydrochloride -

LB911 - Analysis of Metformin Hydrochloride -

LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

Application Search